Amgen share price logo

Amgen

NASDAQ: AMGN

Mega Cap

$385.74

+5.96

(+1.57%)

as on

Amgen Stock Performance

as on September 19, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $378.16
    $386.48
    downward going graph

    1.97%

    Downside

    0.19%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $269.77
    $447.03
    downward going graph

    30.06%

    Downside

    15.89%

    Upside

    downward going graph

Amgen share price movements today

Previous Close
$379.78
Open
$378.36
Volume
1.4M
Market Cap
$203.1B
Dividend Yield
2.64%
Day's Low - High
$378.16 - $386.48
52 Week Low - High
$269.77 - $447.03

Amgen Historical Returns

1 Month Return
-14.15 %
3 Month Return
+ 12.49 %
1 Year Return
+ 33.06 %
3 Year Return
+ 43.69 %
5 Year Return
+ 73.12 %

Amgen Stock Fundamentals & Key Indicators

Check Amgen market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$203.1B

EPS (TTM)

16.22

Dividend Yield

2.64%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

23.41

Industry PE ratio

25.75

PEG Ratio

0.7396518385026407

EBITDA

16.5B

Revenue (TTM)

38.1B

Profit Margin

72.65%

Return On Equity TTM

89.32%

Amgen Stock Valuation

Track how Amgen P/E has moved over time to understand its valuation trends.

Amgen in the last 5 years

  • Overview

  • Trends

Lowest (21.57x)

December 31, 2022

Today (22.84x)

December 31, 2025

Industry (25.75x)

December 31, 2025

Highest (34.20x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: 22.84x

Amgen vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Amgen with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$203.1B73.12%23.4172.65%2.64%
BUY$1.1T400.84%38.5583.40%0.59%
BUY$464.8B145.08%74.171.48%2.60%
BUY$643.9B64.02%31.2467.91%1.98%
BUY$354.8B105.29%115.014.77%2.35%

Stock Returns calculator for Amgen Stock including INR - Dollar returns

The Amgen stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Amgen investment value today

Current value as on today

₹1,46,900

Returns

₹46,900

(+46.9%)

Returns from Amgen Stock

₹35,153 (+35.15%)

Dollar Impact

₹11,747 (+11.75%)

Analyst Recommendation on Amgen Stock

Based on 24 analysts

BUY

37.50%

Buy

54.17%

Hold

8.33%

Sell

Based on 24 analysts, 54.166666666666664% of analysts recommend a 'BUY' rating for Amgen. Average target price of $388.03

Amgen Share Price Target

Get share price movements and forecasts by analysts on Amgen.

What analysts predicted

0.59%UPSIDE

Target Price

$388.03

Current Price

$385.74

Analyzed by

24 Analysts

Target

$388.03

Amgen target price $388.03, a slight upside of 0.59% compared to current price of $385.74. According to 24 analysts rating.

Indian Investors' Interest in Amgen Stock

Investment in Amgen Shares on INDmoney has grown by 97.50% in the last 30 days, indicating increased investment activity.

Time period: to

Change:97.50% versus previous 30 day period

Search interest for Amgen Stock has increased by 51% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:51% versus previous 30 day period

Amgen Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
7,447
8,388
8,503
9,086
8,149
9,167
9,557
9,896
8,618
10,054
Gross Profit
4,247
5,152
5,193
5,974
5,181
6,156
6,475
8,106
5,874
7,243
Operating Income
991
1,909
2,047
2,311
1,178
2,644
2,526
3,942
2,666
3,514
EBITDA
2,155
3,002
5,273
2,926
4,083
3,617
5,913
3,299
3,857
3,441
Interest Expense
824
808
776
747
723
708
685
653
657
673
Depreciation
1,399
1,400
1,396
1,397
1,387
1,341
1,307
1,132
1,116
-
Income Before Tax
-68
794
3,101
782
1,973
1,568
3,921
1,514
2,084
2,768
Income Tax Expense
45
48
271
155
243
136
705
181
265
393
Net Income
-113
746
2,830
627
1,730
1,432
3,216
1,333
1,819
2,375
Net Profit Margin
57.03%
61.42%
61.07%
65.75%
63.58%
67.15%
67.75%
81.91%
68.16%
72.04%

Amgen Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
22,849
23,747
23,362
25,424
25,979
26,323
28,190
33,424
36,741
Gross Profit
18,780
19,646
19,006
19,265
19,525
19,917
19,775
20,566
26,012
Operating Income
9,973
10,263
9,674
9,139
7,639
9,566
7,897
7,258
10,676
EBITDA
12,856
12,883
12,633
12,996
11,296
12,169
14,801
13,356
16,898
Interest Expense
1,304
1,392
1,289
1,262
1,197
1,406
2,875
3,155
2,755
Depreciation
1,955
1,946
2,206
3,601
3,398
3,417
4,071
5,592
5,167
Income Before Tax
9,597
9,545
9,138
8,133
6,701
7,346
7,855
4,609
8,976
Income Tax Expense
7,618
1,151
1,296
869
808
794
1,138
519
1,265
Net Income
1,979
8,394
7,842
7,264
5,893
6,552
6,717
4,090
7,711
Net Profit Margin
82.19%
82.73%
81.35%
75.77%
75.16%
75.66%
70.15%
61.53%
70.80%

Amgen Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-113
746
2,830
627
1,730
1,432
3,216
1,333
1,819
-1,819
Operating Cash Flow
689
2,459
3,571
4,771
1,391
2,280
4,684
1,603
2,189
4,002
Investing Cash Flow
-217
-217
-210
-402
-447
-389
-414
-693
-716
-569
Financing Cash Flow
-1,708
-2,649
-3,651
-1,407
-4,107
-2,673
-2,853
-1,226
1,436
-1,482
Change in Cash
-1,236
-407
-290
2,962
-3,163
-782
1,417
-316
2,909
1,951

Amgen Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
1,979
8,394
7,842
7,264
5,893
6,552
6,717
4,090
7,711
Operating Cash Flow
11,177
11,296
9,150
10,497
9,261
9,721
8,471
11,490
9,958
Investing Cash Flow
-4,024
14,339
5,709
-5,401
733
-6,044
-26,204
-1,046
-1,943
Financing Cash Flow
-6,594
-22,490
-15,767
-4,867
-8,271
-4,037
21,048
-9,415
-10,859
Change in Cash
559
3,145
-908
229
1,723
-360
3,315
1,029
-2,844

Mutual Funds that own Amgen Stock

Check out the Mutual Funds with significant holdings in Amgen.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
6.737405%
36424571
Fidelity Concord Street Trust
1.752463%
9474379
Income Fund of America
1.407392%
7608812
Washington Mutual Investors Fund
1.338847%
7238238
American Balanced Fund
1.283717%
6940187

Global Institutional Holdings in Amgen

Funds
Holdings
Vanguard
9%
iShares
6.06%
SPDR
4.99%
Invesco
3.84%
Schwab
2.59%

Amgen News & Key Events

  • img

    Today's Timeline - 15 September

    Tue, 03:10 PM

    -

    FDA reduces monitoring time for Amgen’s Imdelltra infusions, simplifying patient care for ES-SCLC treatment.

    Tue, 04:33 PM

    -

    Amgen plans to deploy Veeva Vault CRM globally to enhance therapy delivery speed and agility.

    Tue, 11:02 PM

    -

    Amgen reports strong revenue growth and pipeline advances, enhancing long-term outlook.

Insights on Amgen

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Amgen Inc. has seen a positive trend in its revenue over the last two quarters. Revenue increased from $8.61 billion to $10.05 billion, representing an average growth of 14.3% per quarter.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Amgen Inc. has shown strong performance over the last three quarters, with its net profit increasing from $1.33 billion to $2.37 billion. This represents an average growth of 25.1% per quarter.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, AMGN has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, AMGN stock has moved up by 37.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Merck & Co., Inc. has given 80.5% return, outperforming this stock by 42.8%

About Amgen

Amgen Inc., established in 1980 and headquartered in Thousand Oaks, California, is a global biotechnology leader focused on discovering, developing, manufacturing, and delivering groundbreaking human medicines. The company's scientific endeavors span several critical therapeutic categories, including inflammatory conditions, oncology and hematology, bone health, cardiovascular diseases, nephrology, and neuroscience. Its extensive portfolio features a range of significant pharmaceutical products. Notable examples include Enbrel, prescribed for conditions like plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, which helps cancer patients by reducing the risk of infection linked to a low white blood cell count; Prolia, utilized in postmenopausal women to combat osteoporosis; and Xgeva, designed to prevent skeletal-related complications. Otezla offers relief for adult patients suffering from plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease. Aranesp addresses anemia and low red blood cell counts, while KYPROLIS is employed to treat patients with relapsed or refractory multiple myeloma. Furthermore, Repatha plays a vital role in lowering the incidence of major cardiovascular events such as myocardial infarction, stroke, and coronary revascularization. Amgen's comprehensive product lineup also encompasses Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. The company distributes its therapies worldwide, primarily serving healthcare providers, including physicians and their clinics, dialysis centers, hospitals, and pharmacies. Distribution is facilitated through pharmaceutical wholesale distributors, complemented by direct-to-consumer channels. Amgen actively engages in strategic collaborations. It has partnered with entities such as Novartis Pharma AG, UCB, Bayer HealthCare LLC, BeiGene, Ltd., Eli Lilly and Company, Datos Health, and Verastem, Inc., to jointly assess VS-6766 when combined with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. Another key alliance involves Kyowa Kirin Co., Ltd., for the co-development and commercialization of KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody targeting atopic dermatitis and other autoimmune conditions. Additionally, Amgen maintains research and development partnerships with Neumora Therapeutics, Inc. and Plexium, Inc.
OrganisationAmgen
HeadquartersOne Amgen Center Drive, Thousand Oaks, CA, 91320-1799, US
IndustryDrug Manufacturers - General
CEORobert A. Bradway
E-voting on sharesClick here to vote

Key Management of Amgen

Name

Title

Mr. Robert A. Bradway

Chairman & CEO

Mr. Murdo Gordon

Executive Vice President of Global Markets and Policy

Mr. Thomas J. W. Dittrich

Executive VP & CFO

Mr. Howard Y. Chang M.D., Ph.D.

Senior VP of Global Research & Chief Scientific Officer

Mr. Sean Bruich

SVP & Chief Technology Officer

Mr. Scott Skellenger

Senior VP & Chief Information Officer

Mr. Peter H. Griffith

Executive Vice President

Dr. James E. Bradner M.D.

EVP of Research & Development, Artificial Intelligence and Data

Mr. Esteban Santos

Executive Vice President of Operations

Mr. Matthew C. Busch

Chief Accounting Officer & VP of Finance

FAQs

What is Amgen share price today?

Amgen share price today is $385.74 as on at the close of the market. Amgen share today touched a day high of $386.48 and a low of $378.16.

What is the 52 week high and 52 week low for Amgen share?

Amgen share touched a 52 week high of $447.03 on and a 52 week low of $269.77 on . Amgen stock price today i.e. is closed at $385.74,which is 13.71% down from its 52 week high and 42.99% up from its 52 week low.

What is Amgen's market capitalisation today?

Amgen market capitalisation is $0.20T as on .

How to invest in Amgen Stock (AMGN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Amgen on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Amgen Shares that will get you 0.0039 shares as per Amgen share price of $385.74 per share as on September 19, 2026 at 1:29 am IST.

What is the minimum amount required to buy Amgen Stock (AMGN) from India?

Indian investors can start investing in Amgen (AMGN) shares with as little as ₹95.8725 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.73 in Amgen stock (as per the Rupee-Dollar exchange rate as on ). Based on Amgen share’s latest price of $385.74 as on September 19, 2026 at 1:29 am IST, you will get 0.0259 shares of Amgen. Learn more about fractional shares .

What are the returns that Amgen has given to Indian investors in the last 5 years?

Amgen stock has given 73.12% share price returns and 30.29% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?